© 2021 MJH Life Sciences and Cure Today. All rights reserved.
© 2021 MJH Life Sciences™ and Cure Today. All rights reserved.
July 29th 2021, 12:00am
By Michelle Velez
It wasn’t just a miscarriage, it was a rare type of cancer called choriocarcinoma.
July 28th 2021, 11:00pm
By Brielle Benyon
Opdivo was granted an accelerated approval for patients with hepatocellular carcinoma, but the indication was pulled after follow-up data failed to show that the agent improved survival over another drug.
July 28th 2021, 9:00pm
By Darlene Dobkowski, MA
Although CLL follows a different staging format than other cancer types, diagnosing the disease properly can open the doors for more effective treatment and management strategies.
July 28th 2021, 6:00pm
By Janie McCutchen
A patient with ovarian cancer details the compassion she experienced with her oncology nurse even during the COVID-19 pandemic.
July 28th 2021, 4:00pm
By Julie S. Brokaw
An ovarian cancer survivor shares her experience receiving a radiation treatment on her lymph nodes.
July 28th 2021, 3:00pm
By Antonia DePace
Maintaining health before and after a diagnosis of myeloproliferative neoplasms could help patients as they undergo treatment.
July 28th 2021, 2:04pm
Online resources available to patients with lung or thyroid cancer who are considering participation in a clinical trial after undergoing comprehensive genomic profiling.
July 28th 2021, 1:58pm
The pros and cons of conducting pathology assessments for comprehensive biomarker tests in central laboratories versus local laboratories.
July 28th 2021, 1:00pm
By Jamie Cesanek
The Major Histocompatibility Complex Class II protein has potential to predict immunotherapy benefit in two types of breast cancer.
July 27th 2021, 9:00pm
An online tool developed by oncologists for this rare diagnosis individualizes survival estimates, resulting in candid discussions and better decision-making.
July 27th 2021, 6:00pm
Study findings from China show that a new treatment option improves survival outcomes in nasopharyngeal carcinoma, but can U.S. populations expect similar results?
July 27th 2021, 4:00pm
By Martha Carlson
“Each of us has our own way of marking what cancer brings to our lives, sometimes in a simple three-letter word,” writes a woman with breast cancer.
July 27th 2021, 3:00pm
Fewer opioids have been prescribed, but there have been more emergency room visits for pain in patients with cancer who have poor prognoses.
July 27th 2021, 2:13pm
Dr Thomas E. Hutson comments on the rationale for using combination immune therapy, as well as a combination of immune therapy and an oral VEGF inhibitor for initial treatment of RCC.
July 27th 2021, 2:09pm
Kidney cancer expert, Dr Thomas E. Hutson, shares insight on managing adverse events resulting from combination therapy in RCC.
Molar Pregnancy Survivor Shares Her Rare Cancer Story
Opdivo Regimen Pulled for Liver Cancer Treatment
Navigating Chronic Lymphocytic Leukemia Diagnosis and Staging
‘Treadmill of Survivorship’ With a Supportive Oncology Nurse